
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
P
PFE
Pfizer Inc.
$27.05
+0.44 (+1.65%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$27.05
Live market price
P/E (TTM)
19.89
EPS: $1.36
P/S (TTM)
2.46
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 5:56:03 AM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
146.4M
% of Float
3.0%
Days to Cover
2.5
Avg Daily Vol
58.1M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.97
Leverage ratio
ROE (TTM)
9.00%
Return on equity
Income Statement
Revenue
$62.58B
Cost of Revenue
$16.07B
Gross Profit
$46.51B
Operating Income
$7.52B
Net Income
$7.81B
EPS (Quarter)
$1.36
EPS (TTM)
--
Balance Sheet
Total Assets
$208.16B
Total Liabilities
$121.39B
Shareholders' Equity
$86.78B
Current Assets
$42.90B
Current Liabilities
$36.98B
Cash & Equivalents
--
Long-Term Debt
--
Cash Flow
Operating Cash Flow
$11.70B
Investing Cash Flow
$-1.35B
Financing Cash Flow
$-10.30B
Free Cash Flow
$10.35B
Profitability Margins
Gross Margin
74.33%
Operating Margin
12.02%
Net Profit Margin
12.48%
ROA (TTM)
3.75%
ROE (TTM)
9.00%
Data source: Polygon.io
Last updated: 3/8/2026, 5:56:04 AM
Company Profile
Symbol
PFE
Market Cap
$153.81B
IPO Date
Jun 22, 1951
CEO
Albert Bourla
Employees
75,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Read MoreSimilar Stocks
MRNA
Moderna Inc.
$52.52
-2.43%
MRK
Merck & Co., Inc.
$115.79
-0.24%
JNJ
Johnson & Johnson
$240.40
+0.32%